Impact of a selective cyclooxygenase-2 inhibitor, celecoxib, on cortical excitability and electrophysiological properties of the brain in healthy volunteers: A randomized, double-blind, placebo-controlled study.

PLoS One · 2019 · PMC6386435 · PMID 30794658

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

an increasing trendp = 0.06so close (0.05 < p ≤ 0.1)

The sum of power recorded from all electrodes was not altered significantly by celecoxib treatment, while it showed an increasing trend in the celecoxib group, especially at 4 hours after initial administration ( p = 0.06).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.